Home › Funds › ALLIANCEBERNSTEIN L.P. › APH

ALLIANCEBERNSTEIN L.P. position in APH

AMPHENOL CORP · Technology

ALLIANCEBERNSTEIN L.P. reported holding 15,444,587 shares of APH (AMPHENOL CORP) in its Q3 2026 13F filing — a position valued at US$1.30B, representing 0.41% of its reported portfolio and ranking #47 among its reported holdings. ALLIANCEBERNSTEIN L.P. has disclosed APH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)15.44M sh
Reported value held$1.30B
Portfolio Weight0.41%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How ALLIANCEBERNSTEIN L.P.'s APH position evolved

ALLIANCEBERNSTEIN L.P. first disclosed a stake in APH in Q3 2023 at 9,297,796 shares (US$780.9M). The position peaked in Q3 2026 at 15,444,587 shares, worth US$1.30B. Across 13 filings, ALLIANCEBERNSTEIN L.P. increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 15,444,587 shares valued at US$1.30B — an increase of 9,378,029 shares quarter over quarter.. Notable position changes include a 84% increase in Q2 2024 (shares fell 3% over the following quarter), a 49% increase in Q2 2026 (shares fell 4% over the following quarter), a 155% increase in Q3 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.30M $780.92M New
Q4 2023 8.98M $890.25M Reduce
Q1 2024 7.99M $921.31M Reduce
Q2 2024 14.69M $989.64M Add
Q3 2024 14.92M $972.38M Add
Q4 2024 8.65M $600.54M Reduce
Q1 2025 8.74M $573.23M Add
Q2 2025 8.03M $792.55M Reduce
Q3 2025 7.19M $889.96M Reduce
Q4 2025 5.17M $699.26M Reduce
Q1 2026 4.07M $550.69M Reduce
Q2 2026 6.07M $766.51M Add
Q3 2026 15.44M $1.30B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APH and 13F data

APH (AMPHENOL CORP) is a Technology company. 44 other funds we track also report a position in APH — the largest reported positions include Fidelity Management & Research (FMR) (US$10.58B), Capital International Investors (US$7.30B), PRICE T ROWE ASSOCIATES INC /MD/ (US$6.08B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APH

All APH fund holders →

FAQ

How long has ALLIANCEBERNSTEIN L.P. held APH?

ALLIANCEBERNSTEIN L.P. has disclosed APH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ALLIANCEBERNSTEIN L.P.'s current position in APH?

As of Q3 2026, ALLIANCEBERNSTEIN L.P. holds 15.44M shares of APH (AMPHENOL CORP), valued at $1.30B, representing 0.41% of its reported portfolio and ranking #47.

Has ALLIANCEBERNSTEIN L.P. been buying or selling APH?

In the latest 13F filing (Q3 2026), ALLIANCEBERNSTEIN L.P. increased its position in APH. The position peaked in Q3 2026 at 15.44M shares.

Which other funds hold APH?

Other major institutional holders of APH include Fidelity Management & Research (FMR), Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.